Abstract
Errors due to look-alike or sound-alike medication names are common in the United States, and are responsible for thousands of deaths and millions of dollars in cost each year. Up to 25% of all medication errors are attributed to name confusion, and 33% to packaging and/or labeling confusion. Thousands of medication name pairs have been confused based on similar appearances or sounds when written or spoken, or have been identified as having the potential for confusion. Systems and recommendations have been developed that may reduce the occurrence of such errors.
Similar content being viewed by others
REFERENCES
Brennan, T. A., Leape, L. L., Laird, N. M., Hebert, L., Localio, A. R., Lawthers, A. G., Newhouse, J. P., Weiler, P. C., and Hiatt, H., Incidence of adverse events and negligence in hospitalized patients. Results of the Harvard Medical Practice Study I. N. Engl. J. Med. 324(6):370–376, 1991.
Thomas, E. J., Studdert, D. M., Burstin, H. R., Orav, E. J., Zeena, T., Williams, E. J., Howard, K. M., Weiler, P. C., and Brennan, T. A., Incidence and types of adverse events and negligent care in Utah and Colorado. Med. Care. 38(3):261–271, 2000.
Bates, D. W., Cullen, D. J., Laird, N., Petersen, L. A., Small, S. D., Servi, D., Laffel, G., Sweitzer, B. J., Shea, B. F., Hallisey, R., Vander Vliet, M., Nemeskal, R., and Leape, L. L.; for the ADE Prevention Study Group. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA 274(1):29–34, 1995.
Leape, L. L., Brennan, T. A., Laird, N., Lawthers, A. G., Localio, A. R., Barnes, B. A., Hebert, L., Newhouse, J. P., Weiler, P. C., and Hiatt, H., The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II. N. Engl. J. Med. 324(6):377–384, 1991.
Institute of Medicine, To Err Is Human, Full text available at http://www.nap.edu/books/0309068371/html/.
Bates, D. W., Spell, N., Cullen, D. J., Burdick, E., Laird, N., Petersen, L. A., Small, S. D., Sweitzer, B. J., and Leape, L. L., The costs of adverse drug events in hospitalized patients. JAMA 277(4):307–311, 1997.
Schneider, P. J., Gift, M. G., Lee, Y. P., Rothermich, E. A., and Sill, B. E., Cost of medication-related problems at a university hospital. Am. J. Health Syst. Pharm. 52(21):2415–2418, 1995.
Lazarou, J., Pomeranz, B. H., and Corey, P. N., Incidence of adverse drug reactions in hospitalized patients: A meta-analysis of prospective studies. JAMA 279(15):1200–1205, 1998.
Chyka, P. A., How many deaths occur annually from adverse drug reactions in the United States? Am. J. Med. 109(2):122–130, 2000.
Phillips, D. P., Christenfeld, N., and Glynn, L. M., Increase in US medication-error deaths between 1983 and 1993. Lancet 351(9103):643–644, 1998.
Aiming at Administering: Practice Recommendations to Prevent Errors. USP Quality Review No. 71, January 2000. Available at http://www.usp.org/reporting/review/qr71.pdf.
Leape, L. L., Bates, D. W., Cullen, D. J., Cooper, J., Demonaco, H. J., Gallivan, T., Hallisey, R., Ives, J., Laird, N., Laffel, G., Nemeskal, R., Petersen, L. A., Porter, K., Servi, D., Shea, B. F., Small, S. D., Sweitzer, B. J., Thompson, B. T., and Vander Vliet, M.: for the ADE Prevention Study Group. Systems analysis of adverse drug events. ADE Prevention Study Group. JAMA 274(1):35–43, 1995.
Lesar, T. S., Briceland, L., and Stein, D. S., Factors related to errors in medication prescribing. JAMA 277(4):312–317, 1997.
Stop, Look and Listen! USP Quality Review No. 49, July 1995. Available at www.usp.org.
For Regulators and Standard-Setters. USP Quality Review No. 62, May 1998. Available at www.usp.org/reporting/review/rev_062f.htm.
Lambert, B. L., Predicting look-alike and sound-alike medication errors. Am. J. Health Sys. Pharm. 54(10):1161–1171, 1997.
USAN Stem List. Available at http://www.ama-assn.org/ama1/pub/upload/mm/365/usanstemlist_021003.doc.
Three Is a Crowd... USP Quality Review No. 68. September 1999. Available at http://www.usp.org/reporting/review/qr68.pdf.
Amrinone Becomes Inamrinone. USP Quality Review No. 73, March 2000. Available at http://www.usp.org/reporting/review/qr73.pdf.
Kenagy, J. W., and Stein, G. C., Naming, labeling, and packaging of pharmaceuticals. Am. J. Health Syst. Pharm. 58:2033–2041, 2001.
Use Caution, Avoid Confusion. USP Quality Review No. 76, March 2001. Available at http://www.usp.org/reporting/review/qr76.pdf.
Billups, N. F., and Billups, S. M. (eds.), American Drug Index (46th ed.) Kluwer, St. Louis, MN, 2002.
Lambert, B. L., Lin, S. J., Chang, K. Y., and Gandhi, S. K., Similarity as a risk factor in drug-name confusion errors: The look-alike (orthographic) and sound-alike (phonetic) model. Med. Care 37(12):1214–1225, 1999.
ISMP Medication Safety Alert, Vol. 7,No. 7, April 3, 2002.
Schwab, M., Oetzel, C., Mörike, K., Jägle, C., Gleiter, C. H., and Eichelbaum, M., Using trade names as a risk factor for accidental drug overdose. Arch. Intern. Med. 1065–1066, 2002.
Cohen, M. R., Trade names, INNs, and medication errors. Arch. Intern. Med. 162(22):2636, 2002.
Product Content Confusion. USP Quality Review No. 54, May 1996. Available at http://www.usp.org/reporting/review/rev_054b.htm.
Unintentional Acetaminophen Overdosing. USP Quality Review No. 54, May 1996. Available at http://www.usp.org/reporting/review/rev_054c.htm.
“Verapamil” in Clinical Pharmacology Section of Physicians Online. Available at www.pol.net (physicians only).
ISMP Medication Safety Alert, Vol. 7,No. 12, June 12, 2002.
ISMP Medication Safety Alert, Vol. 7,No. 14, July 10, 2002.
ISMP Medication Safety Alert, Vol. 7,No. 17, August 21, 2002.
Rajski, M. J., Medication naming, labeling, and packaging. Am. J. Health Syst. Pharm. 59(9):877, 2002.
ISMP Medication Safety Alert, Vol. 7,No. 2, January 23, 2002.
Mitka, M., What's in a (drug) name? Plenty! JAMA 282(15):1409–1410, 1999.
Look-Alike, Sound-Alike Drug Names. JCAHO Sentinel Event Alert No. 19, May 2001. Available at www.jcaho.org/about+us/news+letters/sentinel+event+alert/sea_19.htm.
FDA Name Differentiation Project. Available at http://www.ismp.org/msaarticles/drugnames.html.
Symonds, J. K., and Robertson, W. O., Drug identification: Use of coded imprint. JAMA 199:158–160, 1967.
Vasudevan, P., Del Gianni, T., and Robertson, W. O., Avoiding medication mixups. Identifiable imprint codes. West. J. Med. 165(6):352–354. 1996. Abstract available via Medline.
FDA Proposes Drug Bar Code Regulation. FDA News, March 13, 2003. Available at http://www.fda.gov/oc/initiatives/barcode-sadr/fs-barcode.html.
Young, D., Health care industry informs FDA of bar-code needs. Am. J. Health Syst. Pharm. 59(17):1592, 2002.
Policy Statement: Color Codes for Topical Ocular Medications. American Academy of Ophthalmology, February 2000. Available at www.aao.org/aao/member/policy/color.cfm.
Radhakrishna, S., Syringe labels in anaesthetic induction rooms. Anaesthesia 54(10):963–968, 1999.
Cohen, M. R., Medication naming, labeling and packaging. Am. J. Health Syst. Pharm. 59(9):876–877, 2002.
ISMP Medication Safety Alert, Vol. 8,No. 1, January 9, 2003.
Ophthalmic Products Similar Packaging/Labeling Initiates Changes. Practioners' Reporting News, May 8, 2002. Available via www.usp.org.
It Doesn't Pay to Play the Percentages. ISMP Medication Safety Alert, Vol. 7,No. 21, 2002.
Medication Error Related to Potentially Dangerous Abbreviations. JCAHO Sentinel Event Alert No. 23, September 2001. vailable at http://www.jcaho.org/ about+us/news+letters/sentinel+event+alert/sea_23.htm.
ISMP Medication Safety Alert, Vol. 7,No. 22, 2002.
Wheeler, J., and Shah, P., Reviews: Minerva. BMJ 322:182, 2002.
Safety Briefs. ISMP Medication Safety Alert, Vol. 7,No. 16, 2002.
Robertson, S. O., Alphabet soup. JAMA 244:1902, 1980.
Do Not Use These Dangerous Abbreviations or Dose Designations. Special Issue. Institute for Safe Medical Practices. Available at http://www.ismp.org/msaarticles/specialissuetableprint.htm and http://www.ismp.org/msaarticles/specialissuetable.html
Bates, D. W., Leape, L. L., Cullen, D. J., Laird, N., Petersen, L. A., Teich, J. M., Burdick, E., Hickey, M., Kleefield, S., Shea, B., Vander Vliet, M., and Seger, D. L., Effect of computerized physician order entry and a team intervention on prevention of serious medication errors. JAMA 280(15):1311–1316, 1998.
Safety Briefs. ISMP Medication Safety Alert, Vol. 7,No. 8, April 17, 2002.
Meyer, T. A., Improving the quality of the order-writing process for inpatient orders and outpatient prescriptions. Am. J. Health Syst. Pharm. 57(Suppl. 4):S18–S22, 2000.
Anonymous. A study of physicians' handwriting as a time waster. JAMA 242:2429–2430, 1979.
Recommendations for Prescription Writing. USP Quality Review No. 57, January 1997. Available at www.usp.org.
Dean, B. S., Allan, E. L., Barber, N. D., and Barker, K. N., Comparison of medication errors in an American and a British hospital. Am. J. Health Syst. Pharm. 52(22):2543–2549, 1995.
Cohen, M. R., Understanding and preventing drug misadventures: Drug product characteristics that foster drug-use-system errors. Am. J. Health Syst. Pharm. 52(4):395–399, 1995.
Safety Briefs. ISMP Medication Safety Alert, Vol. 7,No. 9, May 1, 2002.
Phillips, J., Beam, S., Brinker, A., Holquist, C., Honig, P., Lee, L., Parner, C. Retrospective analysis of mortalities associated with medication errors. Am. J. Health Sys. Pharm. 58(19):1835–1841, 2001.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Berman, A. Reducing Medication Errors Through Naming, Labeling, and Packaging. Journal of Medical Systems 28, 9–29 (2004). https://doi.org/10.1023/B:JOMS.0000021518.60670.10
Issue Date:
DOI: https://doi.org/10.1023/B:JOMS.0000021518.60670.10